Polar Capital Holdings’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,065,564
Closed -$62.9M 272
2025
Q2
$62.9M Buy
1,065,564
+15,184
+1% +$981K 0.33% 76
2025
Q1
$76.9M Buy
1,050,380
+279,467
+36% +$23.1M 0.47% 62
2024
Q4
$63.8M Buy
+770,913
New +$60.8M 0.36% 73
2023
Q1
Sell
-723,454
Closed -$53.7M 308
2022
Q4
$53.7M Sell
723,454
-1,854
-0.3% -$126K 0.43% 78
2022
Q3
$43.2K Buy
725,308
+11,960
+2% +$720K 0.28% 86
2022
Q2
$40K Sell
713,348
-14,570
-2% -$958K 0.24% 95
2022
Q1
$53.7K Sell
727,918
-26,286
-3% -$1.83M 0.24% 94
2021
Q4
$54.5K Buy
754,204
+40,167
+6% +$2.92M 0.2% 99
2021
Q3
$54.7K Sell
714,037
-57,700
-7% -$4.63M 0.22% 102
2021
Q2
$59.8K Buy
771,737
+71,585
+10% +$5.09M 0.26% 90
2021
Q1
$43.2M Buy
700,152
+357,294
+104% +$22.6M 0.27% 96
2020
Q4
$22.4M Buy
+342,858
New +$19.7M 0.14% 145

Other funds holding GMED

Polar Capital Holdings's GMED Position: Q3 2025 in Review

Polar Capital Holdings sold out of Globus Medical (GMED) in Q3 2025, closing a stake of 1,065,564 shares — an estimated $62.9M sold.

Polar Capital Holdings first reported a position in GMED in Q4 2020 and held it in 12 quarters. The position peaked at $76.9M in Q1 2025. 489 funds tracked by Wall St. Rank hold GMED as of Q3 2025.

  • Polar Capital Holdings reported no remaining Globus Medical position as of Q3 2025 after selling out during the quarter.
  • Polar Capital Holdings sold 1,065,564 Globus Medical shares in Q3 2025, an estimated $62.9M.
  • Polar Capital Holdings first reported a position in Globus Medical in Q4 2020 and held it in 12 quarters.
  • Polar Capital Holdings's Globus Medical position peaked at $76.9M in Q1 2025.
  • 489 funds tracked by Wall St. Rank held Globus Medical as of Q3 2025.

Based on Polar Capital Holdings's 13F filing for Q3 2025, filed 14 Nov 2025.